{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-034619","form_type":"8-K","ticker":"APYX","cik":"0000719135","company_name":"Apyx Medical Corp","filed_at":"2026-07-24T21:18:18+00:00","discovered_at":"2026-07-24T21:20:00.271729+00:00","generated_at":"2026-07-24T21:20:05.618213+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Apyx Medical reconstitutes board committees; Executive Chairman Vizirgianakis steps off all committees","bullets":["Audit Committee: Lawrence J. Waldman (Chair), Minnie Baylor-Henry, Wendy Levine.","Governance & Nominating: Baylor-Henry (Chair), Waldman, Levine; Regulatory Compliance: Baylor-Henry (Chair), Waldman, Levine; Compensation: Levine (Chair), Waldman, Baylor-Henry.","Stavros Vizirgianakis, appointed Executive Chairman June 11, 2026, will not serve on any committee.","Board determined all three members independent; Waldman qualifies as audit committee financial expert."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-034619","json":"https://secwatch.observer/filing/0001493152-26-034619.json","markdown":"https://secwatch.observer/filing/0001493152-26-034619.md","text":"https://secwatch.observer/filing/0001493152-26-034619.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/719135/000149315226034619/0001493152-26-034619-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/719135/000149315226034619/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-24T21:20:05.618213+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}